Board Of Directors' Annual Report

Overview

The report records Group revenue of 3,062 million Saudi Riyals in 2024, with pharmaceuticals contributing 48% of revenue. It highlights the divestment of Astra Mining and a strategic focus on pharmaceuticals and specialty chemicals. The company also describes humanitarian support, job localization, women's participation, student development, and employee health awareness as social-responsibility activities.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2024
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services